The Russian Direct Investment Fund (RDIF) has signed agreements with Spain, Italy, France and Germany for the production of the coronavirus vaccine 'Sputnik V', as reported by the Sputnik agency, alluding to a statement issued by Kiril Dmítriev CEO of the Russian Direct Investment Fund.
"The RDIF reached agreements with companies from Italy, Spain, France and Germany to commence production of 'Sputnik V' which "will allow supplies of the Russian vaccine to begin once it receives the approval of the European Medicines Agency (EMA)," said Dmítriev.
It is also understood that the RDIF and its existing partners are willing to begin shipments to EU countries that register the 'Sputnik V' vaccine on their own account.
Sputnik has a the meaning "attendant", "companion", "travelling companion", "fellow traveler".
This vaccine, developed by the Nikolai Gamaleya Center for Epidemiology and Microbiology with funding from RDIF and approved in Russia on August 11, 2020, was the first covid vaccine registered in the world and has an efficacy of 91.6 percent, according to the results of clinical studies
The drug has been registered for emergency use in more than 50 countries, however it is currently awaiting approval from the EMA for use in the EU but some European countries, such as Hungary and Slovakia, have already authorised its use.
Please help use by sharing this post and of course by visiting www.gospain.co.uk
You can also join our very helpful Facebook group www.facebook.com/groups/gospain.co.uk